Research into peginterferon alfa-2b’s degradation pathways suggest that drug substance be immediately and continuously converted to drug product when the material is in liquid form.
Sanjay Bandyopadhyay
Advertisement
Sanjay Bandyopadhyay is vice president at Cadila Healthcare Ltd.’s Zydus Research Center in Ahmedabad, Gujarat, India;
Articles by Sanjay Bandyopadhyay
Advertisement
Latest Updated Articles
Optimizing Manufacturing Based on the Storage Stability of Pegylated ProductsPublished: October 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
